Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Requirement of GSK-3 for PUMA induction upon loss of pro-survival PI3K signaling.

Schubert F, Rapp J, Brauns-Schubert P, Schlicher L, Stock K, Wissler M, Weiß M, Charvet C, Borner C, Maurer U.

Cell Death Dis. 2018 May 1;9(5):470. doi: 10.1038/s41419-018-0502-4.

2.

CDK9-mediated phosphorylation controls the interaction of TIP60 with the transcriptional machinery.

Brauns-Schubert P, Schubert F, Wissler M, Weiss M, Schlicher L, Bessler S, Safavi M, Miething C, Borner C, Brummer T, Maurer U.

EMBO Rep. 2018 Feb;19(2):244-256. doi: 10.15252/embr.201744311. Epub 2018 Jan 15.

3.

SPATA2: more than a missing link.

Schlicher L, Brauns-Schubert P, Schubert F, Maurer U.

Cell Death Differ. 2017 Jul;24(7):1142-1147. doi: 10.1038/cdd.2017.26. Epub 2017 Mar 10. Review.

4.

SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.

Schlicher L, Wissler M, Preiss F, Brauns-Schubert P, Jakob C, Dumit V, Borner C, Dengjel J, Maurer U.

EMBO Rep. 2016 Oct;17(10):1485-1497. Epub 2016 Jul 25.

5.

GSK-3 - at the crossroads of cell death and survival.

Maurer U, Preiss F, Brauns-Schubert P, Schlicher L, Charvet C.

J Cell Sci. 2014 Apr 1;127(Pt 7):1369-78. doi: 10.1242/jcs.138057.

6.

Increased leukocyte survival and accelerated onset of lymphoma in the absence of MCL-1 S159-phosphorylation.

Lindner SE, Wissler M, Gründer A, Aumann K, Ottina E, Peintner L, Brauns-Schubert P, Preiss F, Herzog S, Borner C, Charvet C, Villunger A, Pahl HL, Maurer U.

Oncogene. 2014 Oct 30;33(44):5221-4. doi: 10.1038/onc.2013.469. Epub 2013 Nov 11.

7.

Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53.

Charvet C, Wissler M, Brauns-Schubert P, Wang SJ, Tang Y, Sigloch FC, Mellert H, Brandenburg M, Lindner SE, Breit B, Green DR, McMahon SB, Borner C, Gu W, Maurer U.

Mol Cell. 2011 Jun 10;42(5):584-96. doi: 10.1016/j.molcel.2011.03.033.

Supplemental Content

Loading ...
Support Center